• Precision Medicine Market
    Medical Devices

    Precision Medicine Market Analysis and Forecast 2020 – 2026

    Precision Medicine Market According to the National Institutes of Health NIH , precision medicine is “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a “one-size-fits-all” approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals. The global Precision Medicine market will reach Volume Million USD in 2019 and with a CAGR xx%…

  • Precision medicine market
    Pharmaceutical and Healthcare

    Precision medicine market Share, Size, Growth and Forecast

    Precision medicine market Market Overview: In 2018, the worldwide market for precision medicines was estimated at USD 48,554.1 million and is estimated at USD 84,590.21 million in 2024, a CAGR of 9.7%. Increasing internet cooperative forums, increasing attempts to characterize genes, and advances in cancer biology are the main factors driving this market growth. The basic idea of precision medicine is to understand the genetic make-up and difference at a population level and at an individual level in order to customize a drug that targets a specific gene type. Sequencing or characterizing genes is therefore the most significant way of gaining data on genes and their possible mutations. The functional…

  • Precision Medicine market
    Pharmaceutical and Healthcare

    Precision Medicine Market 2019 By Demand, End Users, Manufacturers, Revenue Generation, Growth and Forecast 2023

    Global Precision Medicine Market Research: The global precision medicine market has benefitted greatly from advancements in the life science industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive success in the coming years because of the potential to treat and cure chronic illnesses. The market is thus expected to expand at a compound annual growth rate CAGR of 11.60% between 2018 and 2023, generating USD 88.25 Bn in revenue by 2023. Ecosystem player segment insights Diagnostic companies held the largest share of the market in 2018, contributing to approximately 39% of the global revenues. They are expected to continue dominating the market during the…